With a positive phase 3 trial in chronic lymphocytic leukemia (CLL), Eli Lilly hopes to convert Jaypirca’s unique accelerated ...
Just days before his fourth birthday, Santiago was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), the most ...
Chronic lymphocytic leukemia (CLL) has a relatively high survival ... Bone marrow is a soft, spongy substance within bones that produces blood cells. CLL is the result of various genetic mutations ...
(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., today announced the presentation of new clinical data at the 66th American ...
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...
such as chimeric antigen receptor–NK cell treatment. Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have ...
Trying to break from the decade-old practice of using BTK inhibitors indefinitely to treat blood cancer, AstraZeneca has ...
Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease ...
Relapsed chronic lymphocytic leukemia (CLL) occurs when the cancer ... They may then order diagnostic tests to check for the presence of CLL cells in the blood. A peripheral blood smear with ...
Susan L. Slager, PhD, discusses the background of her research on inherited germline genetics for risk of chronic lymphocytic ...
Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline ...